HealthInvest Partners’s McKesson MCK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,000
Closed -$4.42M 54
2022
Q3
$4.42M Buy
13,000
+3,000
+30% +$1.04M 9.33% 7
2022
Q2
$3.26M Sell
10,000
-20,000
-67% -$6.4M 7.52% 8
2022
Q1
$9.18M Sell
30,000
-4,000
-12% -$1.09M 14.62% 1
2021
Q4
$8.45M Buy
34,000
+26,000
+325% +$5.71M 11.91% 2
2021
Q3
$1.59M Sell
8,000
-44,000
-85% -$8.8M 2.39% 14
2021
Q2
$9.94M Buy
52,000
+19,000
+58% +$3.67M 9.42% 5
2021
Q1
$6.44M Sell
33,000
-20,000
-38% -$3.65M 5.13% 11
2020
Q4
$9.22M Buy
+53,000
New +$8.83M 6.1% 9
2017
Q4
$2.78M Sell
17,800
-50,800
-74% -$7.53M 5.86% 6
2017
Q3
$10.5M Buy
68,600
+5,500
+9% +$858K 12.3% 1
2017
Q2
$10.4M Buy
63,100
+12,100
+24% +$1.83M 12.95% 2
2017
Q1
$7.56M Sell
51,000
-6,000
-11% -$879K 11.59% 6
2016
Q4
$8.01M Buy
+57,000
New +$8.38M 7.38% 10
2014
Q1
Sell
-42,100
Closed -$6.79M 19
2013
Q4
$6.79M Buy
+42,100
New +$6.47M 6.76% 9

Other funds holding MCK

HealthInvest Partners's MCK Position: Q4 2022 in Review

HealthInvest Partners sold out of McKesson (MCK) in Q4 2022, closing a stake of 13,000 shares — an estimated $4.42M sold.

HealthInvest Partners first reported a position in MCK in Q4 2013 and held it in 14 quarters. The position peaked at $10.5M in Q3 2017. 1,289 funds tracked by Wall St. Rank hold MCK as of Q4 2022.

  • HealthInvest Partners reported no remaining McKesson position as of Q4 2022 after selling out during the quarter.
  • HealthInvest Partners sold 13,000 McKesson shares in Q4 2022, an estimated $4.42M.
  • HealthInvest Partners first reported a position in McKesson in Q4 2013 and held it in 14 quarters.
  • HealthInvest Partners's McKesson position peaked at $10.5M in Q3 2017.
  • 1,289 funds tracked by Wall St. Rank held McKesson as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.